Cargando…
442. The Results of a Primary Care-based Screening Program for Trypanosoma cruzi in East Boston, Massachusetts
BACKGROUND: This study reports the outcomes of the Strong Hearts pilot project to integrate screening for Trypanosoma cruzi into a primary care setting and facilitate referral for treatment at East Boston Neighborhood Health Center. METHODS: Continuing education about Chagas disease was offered to h...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255584/ http://dx.doi.org/10.1093/ofid/ofy210.451 |
_version_ | 1783373975819124736 |
---|---|
author | Manne-Goehler, Jennifer Davis, Jillian Perez, Juan Huanuco Collins, Katherine Harakawa, Harumi Hochberg, Natasha Hamer, Davidson Barnett, Elizabeth Köhler, Julia |
author_facet | Manne-Goehler, Jennifer Davis, Jillian Perez, Juan Huanuco Collins, Katherine Harakawa, Harumi Hochberg, Natasha Hamer, Davidson Barnett, Elizabeth Köhler, Julia |
author_sort | Manne-Goehler, Jennifer |
collection | PubMed |
description | BACKGROUND: This study reports the outcomes of the Strong Hearts pilot project to integrate screening for Trypanosoma cruzi into a primary care setting and facilitate referral for treatment at East Boston Neighborhood Health Center. METHODS: Continuing education about Chagas disease was offered to healthcare providers, and community-based outreach was provided. One-time screening for all patients ≤50 years old who lived in Mexico, South or Central America for ≥6 months was recommended. The initial screening test was an ELISA performed by a commercial laboratory and confirmatory testing was performed at the US CDC. Confirmed positives were defined as positive on both the screening and confirmatory tests. Confirmed positive patients were referred to the Pediatric and Adult Infectious Disease clinics at Boston Medical Center for further evaluation and treatment. We compared the proportion of confirmed positives by sex, age, and self-reported national origin using chi-squared tests. We then used multivariable logistic regression to examine predictors of (1) confirmed positive or (2) discordant screening and confirmatory testing. RESULTS: A total of 2,183 screening tests were sent; 84 (3.8%) were positive, 2,082 (95.4%) negative, and 17 (0.8%) indeterminate. Among 73 tests with confirmatory results available, 19 (26%) were positive and 54 (74%) negative. All indeterminate tests were confirmed negative. The proportion of confirmed positives increased with increasing age (P = 0.014) (Table 1), but there were no significant differences by sex (M: 8/757, F: 11/1,413, P = 0.51) or national origin (P = 0.79). Nineteen confirmed positives have been evaluated and six initiated benznidazole to date. Three confirmed positives were pregnant. In multivariable models, there were no significant predictors of confirmed positive or discordant testing. CONCLUSION: This pilot shows that integration of screening for Chagas disease is feasible in primary care. Although the prevalence of T. cruzi infection was higher in older age groups, there were no clear demographic predictors of a confirmed positive or discordant test. We also found a high false-positive rate of the screening test, highlighting the need for improved serologic testing options. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6255584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62555842018-11-28 442. The Results of a Primary Care-based Screening Program for Trypanosoma cruzi in East Boston, Massachusetts Manne-Goehler, Jennifer Davis, Jillian Perez, Juan Huanuco Collins, Katherine Harakawa, Harumi Hochberg, Natasha Hamer, Davidson Barnett, Elizabeth Köhler, Julia Open Forum Infect Dis Abstracts BACKGROUND: This study reports the outcomes of the Strong Hearts pilot project to integrate screening for Trypanosoma cruzi into a primary care setting and facilitate referral for treatment at East Boston Neighborhood Health Center. METHODS: Continuing education about Chagas disease was offered to healthcare providers, and community-based outreach was provided. One-time screening for all patients ≤50 years old who lived in Mexico, South or Central America for ≥6 months was recommended. The initial screening test was an ELISA performed by a commercial laboratory and confirmatory testing was performed at the US CDC. Confirmed positives were defined as positive on both the screening and confirmatory tests. Confirmed positive patients were referred to the Pediatric and Adult Infectious Disease clinics at Boston Medical Center for further evaluation and treatment. We compared the proportion of confirmed positives by sex, age, and self-reported national origin using chi-squared tests. We then used multivariable logistic regression to examine predictors of (1) confirmed positive or (2) discordant screening and confirmatory testing. RESULTS: A total of 2,183 screening tests were sent; 84 (3.8%) were positive, 2,082 (95.4%) negative, and 17 (0.8%) indeterminate. Among 73 tests with confirmatory results available, 19 (26%) were positive and 54 (74%) negative. All indeterminate tests were confirmed negative. The proportion of confirmed positives increased with increasing age (P = 0.014) (Table 1), but there were no significant differences by sex (M: 8/757, F: 11/1,413, P = 0.51) or national origin (P = 0.79). Nineteen confirmed positives have been evaluated and six initiated benznidazole to date. Three confirmed positives were pregnant. In multivariable models, there were no significant predictors of confirmed positive or discordant testing. CONCLUSION: This pilot shows that integration of screening for Chagas disease is feasible in primary care. Although the prevalence of T. cruzi infection was higher in older age groups, there were no clear demographic predictors of a confirmed positive or discordant test. We also found a high false-positive rate of the screening test, highlighting the need for improved serologic testing options. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6255584/ http://dx.doi.org/10.1093/ofid/ofy210.451 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Manne-Goehler, Jennifer Davis, Jillian Perez, Juan Huanuco Collins, Katherine Harakawa, Harumi Hochberg, Natasha Hamer, Davidson Barnett, Elizabeth Köhler, Julia 442. The Results of a Primary Care-based Screening Program for Trypanosoma cruzi in East Boston, Massachusetts |
title | 442. The Results of a Primary Care-based Screening Program for Trypanosoma cruzi in East Boston, Massachusetts |
title_full | 442. The Results of a Primary Care-based Screening Program for Trypanosoma cruzi in East Boston, Massachusetts |
title_fullStr | 442. The Results of a Primary Care-based Screening Program for Trypanosoma cruzi in East Boston, Massachusetts |
title_full_unstemmed | 442. The Results of a Primary Care-based Screening Program for Trypanosoma cruzi in East Boston, Massachusetts |
title_short | 442. The Results of a Primary Care-based Screening Program for Trypanosoma cruzi in East Boston, Massachusetts |
title_sort | 442. the results of a primary care-based screening program for trypanosoma cruzi in east boston, massachusetts |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255584/ http://dx.doi.org/10.1093/ofid/ofy210.451 |
work_keys_str_mv | AT mannegoehlerjennifer 442theresultsofaprimarycarebasedscreeningprogramfortrypanosomacruziineastbostonmassachusetts AT davisjillian 442theresultsofaprimarycarebasedscreeningprogramfortrypanosomacruziineastbostonmassachusetts AT perezjuanhuanuco 442theresultsofaprimarycarebasedscreeningprogramfortrypanosomacruziineastbostonmassachusetts AT collinskatherine 442theresultsofaprimarycarebasedscreeningprogramfortrypanosomacruziineastbostonmassachusetts AT harakawaharumi 442theresultsofaprimarycarebasedscreeningprogramfortrypanosomacruziineastbostonmassachusetts AT hochbergnatasha 442theresultsofaprimarycarebasedscreeningprogramfortrypanosomacruziineastbostonmassachusetts AT hamerdavidson 442theresultsofaprimarycarebasedscreeningprogramfortrypanosomacruziineastbostonmassachusetts AT barnettelizabeth 442theresultsofaprimarycarebasedscreeningprogramfortrypanosomacruziineastbostonmassachusetts AT kohlerjulia 442theresultsofaprimarycarebasedscreeningprogramfortrypanosomacruziineastbostonmassachusetts |